Correlation Between 180 Life and ZyVersa Therapeutics

Can any of the company-specific risk be diversified away by investing in both 180 Life and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 180 Life and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between 180 Life Sciences and ZyVersa Therapeutics, you can compare the effects of market volatilities on 180 Life and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 180 Life with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 180 Life and ZyVersa Therapeutics.

Diversification Opportunities for 180 Life and ZyVersa Therapeutics

0.41

Correlation Coefficient

180 Life  ZyVersa Therapeutics

Very weak diversification

The 3 months correlation between 180 and ZyVersa is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding 180 Life Sciences and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and 180 Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 180 Life Sciences are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of 180 Life i.e., 180 Life and ZyVersa Therapeutics go up and down completely randomly.

Pair Corralation between 180 Life and ZyVersa Therapeutics

Given the investment horizon of 90 days 180 Life Sciences is expected to under-perform the ZyVersa Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, 180 Life Sciences is 1.54 times less risky than ZyVersa Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The ZyVersa Therapeutics is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest  107.00  in ZyVersa Therapeutics on December 28, 2024 and sell it today you would lose (33.00) from holding ZyVersa Therapeutics or give up 30.84% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

180 Life Sciences  vs.  ZyVersa Therapeutics

180 Life Sciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days 180 Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

ZyVersa Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with 180 Life and ZyVersa Therapeutics

The main advantage of trading using opposite 180 Life and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 180 Life position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.

The idea behind 180 Life Sciences and ZyVersa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.